BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24879383)

  • 21. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis.
    Linder KA; Kauffman CA; Zhou S; Miceli MH
    Mycoses; 2019 Dec; 62(12):1189-1193. PubMed ID: 31581342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
    Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis.
    Han Y; Wu X; Jiang G; Guo A; Jin Z; Ying Y; Lai J; Li W; Yan F
    BMC Pulm Med; 2023 Feb; 23(1):58. PubMed ID: 36750828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
    BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
    Brownback KR; Pitts LR; Simpson SQ
    Mycoses; 2013 Sep; 56(5):552-8. PubMed ID: 23496321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
    Maertens J; Maertens V; Theunissen K; Meersseman W; Meersseman P; Meers S; Verbeken E; Verhoef G; Van Eldere J; Lagrou K
    Clin Infect Dis; 2009 Dec; 49(11):1688-93. PubMed ID: 19886801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
    Russo A; Giuliano S; Vena A; Lucidi C; Falcone M; Raponi G; Merli M; Venditti M
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):83-6. PubMed ID: 24962954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients.
    Zarrinfar H; Mirhendi H; Makimura K; Satoh K; Khodadadi H; Paknejad O
    Mycopathologia; 2013 Dec; 176(5-6):377-85. PubMed ID: 24045934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis.
    Kabbani D; Bhaskaran A; Singer LG; Bhimji A; Rotstein C; Keshavjee S; Liles WC; Husain S
    J Heart Lung Transplant; 2017 Sep; 36(9):973-979. PubMed ID: 28487045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.